SUPPLEMENTARY METHODS
Cell viability assay. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was performed to assess cell survival. 1,500 cells per well were seeded to the 96-well plate in triplicate. GEM at various concentrations (2.5~20 μM)
were added 24 h later. Three days post treatment, cells were washed with PBS and MTT (5 mg/ml) was added and incubated for 3 h at 37°C. Plates were shaken at room temperature for 15 min and absorbance at 490 nm was recorded with a microplate reader (BioTek Instruments, Winooski, VT). As for the collection of viable cells after GEM treatment, UBC cells were treated with either vehicle (control) or GEM for 3 days and allowed to recover in fresh media for another 3 days.
Flow cytometry. After UBC cells were trypsinized and prepared as single-cell population, CD44 (BD Biosciences, San Jose, CA, USA, 1:25) was incubated with cells in .PBS/0.5% BSA for 15 min at 4°C, followed by the analysis on a BD FACScan flow cytometer.
Plasmid construction and cell transfection. LncRNA-LET promoter and DNA with SMAD binding element deletion (SBE) were generated from human genomic DNA by PCR and cloned into pGL3-basic vector (Promega) at BglII and HindIII sites. For lncRNA-LET overexpression, we cloned lncRNA-LET full length into vector pcDNA3.1 and lentiviral expression vector pCDH, respectively. For lncRNA-LET knockdown, shRNA targeting lncRNA-LET was inserted into the lentiviral expression vector pLKO.1 at AgeI and EcoRI sites. Recombinant lentiviruses were produced by transient transfection of 293FT packaging cells. DNA encoding NF90 was cloned into p3XFlag-CMV10 plasmid at BglII and KpnI sites. Pri-miR-145-WT and pri-miR-145-MUT were cloned into pcDNA3.1. HMGA2-3'UTR, HMGA2-3'UTR mutant, KLF4-3'UTR and KLF4-3'UTR mutant were constructed in psiCHECK2 at XhoI and NotI sites. For cell transfection, 20 μM siRNA or scramble control (Genepharma, Shanghai, China), 1 μg plasmids or empty vector, 50 μM mimic miR-145 or mimic control (RIBOBIO, Guangzhou, China) were transfected into cells using Lipofectamine 3000. Analysis were performed 48 h post transfection. All sequences of siRNAs and mimic miRNAs were presented in Table S1 .
Luciferase assay. Luciferase assays were performed using a luciferase assay kit (Promega). For microRNA, T24 cells in a 24-well plate were transfected with wild-type or mutant KLF4 or HMGA2 3'UTR plasmids with mimic miRNA negative control and mimic miR-145, respectively. 
